Connecting and Innovating for Better Health

We come from many disciplines and backgrounds, united by a vision of a world where better information empowers people to end disease and realize true health.

Building tools and infrastructure, creating care models, and sharing and enabling research are the ways our dedicated investigators and staff express commitment to improving patients’ lives. Their stories fuel our pursuit of the best possible health care for all people. Learn more about how you can join us in revolutionizing care.

Explore our work

 

Regenstrief Public License

Latest News

March 22, 2019 • News
JAMA Viewpoint: Physicians’ trust in one another is a care safety and quality issue
While the importance of trusted relationships between patients and their physicians is taken for granted, little attention has been given to the relationships among physicians themselves. Yet the interactions between, for example, a patient’s primary care physician and cardiologist or between a patient’s pediatrician and an oncology team, are essential to the safety and quality […]
Continue Reading >
March 21, 2019 • News
Regenstrief Showcases Work with State at Indiana Statehouse
A team from Regenstrief Institute displayed its work with the state during MPH Data Day at the Indiana Statehouse. The event was organized by the Indiana Management Performance Hub (MPH) to highlight its partnerships with various state agencies and organizations and demonstrate how data plays an increasingly important role in state government.
Continue Reading >
March 21, 2019 • Executive Update
A Message from Peter Embi, CEO, Part 2: Corporate Partnerships Enhance Efforts to Advance Science
Editor’s Note: Regenstrief Institute has a growing number of important relationships with industry and corporate partners. This is the second column addressing this topic. Periodic updates, as appropriate, may follow. In my February 20th column, I highlighted the growth of Regenstrief Institute’s vital relationships with corporate partners, including Merck, Roche, Eli Lilly, IBM and the […]
Continue Reading >
More News